Goldman Sachs
STDY

Goldman Sachs’s SteadyMed Ltd STDY Stock Holding History

Goldman Sachs’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,249
Closed -$65K – 7111
2017
Q1 		$65K Sell
11,249
-525
-4% -$1.75K ﹤0.01% 6222
2016
Q4 		$31K Sell
11,774
-126
-1% -$429 ﹤0.01% 6530
2016
Q3 		$43K Sell
11,900
-700
-6% -$2.39K ﹤0.01% 6536
2016
Q2 		$41K Sell
12,600
-2,092
-14% -$7.3K ﹤0.01% 6492
2016
Q1 		$36K Sell
14,692
-6,308
-30% -$15.7K ﹤0.01% 6560
2015
Q4 		$68K Hold
21,000
– – ﹤0.01% 6396
2015
Q3 		$75K Sell
21,000
-2,400
-10% -$10.9K ﹤0.01% 6634
2015
Q2 		$124K Sell
23,400
-100
-0.4% -$808 ﹤0.01% 6497
2015
Q1 		$200K Buy
+23,500
New +$201K ﹤0.01% 6022

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs's STDY Position: Q2 2017 in Review

Goldman Sachs sold out of SteadyMed Ltd (STDY) in Q2 2017, closing a stake of 11,249 shares — an estimated $65K sold.

Goldman Sachs first reported a position in STDY in Q1 2015 and held it in 9 quarters. The position peaked at $200K in Q1 2015. 26 funds tracked by Wall St. Rank hold STDY as of Q2 2017.

  • Goldman Sachs reported no remaining SteadyMed Ltd position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 11,249 SteadyMed Ltd shares in Q2 2017, an estimated $65K.
  • Goldman Sachs first reported a position in SteadyMed Ltd in Q1 2015 and held it in 9 quarters.
  • Goldman Sachs's SteadyMed Ltd position peaked at $200K in Q1 2015.
  • 26 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.